FR970M - - Google Patents

Info

Publication number
FR970M
FR970M FR837319A FR837319A FR970M FR 970 M FR970 M FR 970M FR 837319 A FR837319 A FR 837319A FR 837319 A FR837319 A FR 837319A FR 970 M FR970 M FR 970M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR837319A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR837319A priority Critical patent/FR970M/fr
Application granted granted Critical
Publication of FR970M publication Critical patent/FR970M/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
FR837319A 1958-11-04 1960-08-31 Active FR970M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR837319A FR970M (en) 1958-11-04 1960-08-31

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB35428/58A GB870286A (en) 1958-11-04 1958-11-04 Improvements in or relating to 6-methyl-3-oxo-í~-steroid compounds
FR809052A FR1333711A (en) 1958-11-04 1959-11-02 Manufacturing process for 6-methyl-3-oxo-delta4,6-steroids
FR837319A FR970M (en) 1958-11-04 1960-08-31

Publications (1)

Publication Number Publication Date
FR970M true FR970M (en) 1961-12-04

Family

ID=10377599

Family Applications (2)

Application Number Title Priority Date Filing Date
FR809052A Expired FR1333711A (en) 1958-11-04 1959-11-02 Manufacturing process for 6-methyl-3-oxo-delta4,6-steroids
FR837319A Active FR970M (en) 1958-11-04 1960-08-31

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR809052A Expired FR1333711A (en) 1958-11-04 1959-11-02 Manufacturing process for 6-methyl-3-oxo-delta4,6-steroids

Country Status (7)

Country Link
US (1) US3356573A (en)
BE (1) BE584312A (en)
CH (1) CH379493A (en)
DE (1) DE1120446B (en)
FR (2) FR1333711A (en)
GB (1) GB870286A (en)
MY (1) MY6400075A (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1210819B (en) * 1962-03-23 1966-02-17 Ayerst Mckenna & Harrison Process for the preparation of pregnane derivatives alkylated in the 17alpha position
DE1201342B (en) * 1963-03-05 1965-09-23 Olin Mathieson Method of making steroids
US4370321A (en) * 1976-09-01 1983-01-25 Mead Johnson And Company Progestational adjuvant therapy
US4346037A (en) * 1981-07-10 1982-08-24 The Upjohn Company Base catalyzed acylation with enol esters
US5338732A (en) * 1991-06-18 1994-08-16 Bristol-Myers Squibb Company Megestrol acetate formulation
CN1429104A (en) * 1998-03-11 2003-07-09 内部研究股份有限公司 Inhibitors type 5 and type 3 17 beta-hydroxysteroid dehydrogenase and methods for their use
US6268356B1 (en) 1998-04-20 2001-07-31 Pharmaceutical Resources, Inc. Flocculated suspension of megestrol acetate
US6028065A (en) * 1998-04-20 2000-02-22 Pharmaceutical Resources, Inc. Flocculated suspension of megestrol acetate
US6656505B2 (en) 2000-07-21 2003-12-02 Alpharma Uspd Inc. Method for forming an aqueous flocculated suspension
US20030198679A1 (en) * 2000-11-08 2003-10-23 Kundu Subhas C. Flocculated pharmaceutical suspensions and methods for actives
CN106109435B (en) * 2016-07-09 2018-11-06 南京臣功制药股份有限公司 A kind of megestrol acetate capsule and preparation method thereof
CN106137993B (en) * 2016-08-09 2018-11-09 南京臣功制药股份有限公司 A kind of megestrol acetate dispersible tablet and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2311102A (en) * 1940-02-20 1943-02-16 Ciba Pharm Prod Inc Doubly unsaturated ketones and process of making same
CH236309A (en) * 1940-02-20 1945-01-31 Chem Ind Basel Method for representing a, ss; , -difunctional unsaturated ketone.
US2900382A (en) * 1952-06-28 1959-08-18 Syntex Sa Method of making delta4,6 steroid compounds from delta4 steroid compounds
US2882282A (en) * 1957-07-17 1959-04-14 Pfizer & Co C Method of producing 3-keto-delta4, 6-steroid compounds from 3-keto a-ring saturated 6-dihydro steroid compounds
US2891079A (en) * 1959-01-23 1959-06-16 Searle & Co 6-methyl-4, 6-pregnadiene-3, 20-dione and 17alpha-acyloxy derivatives thereof

Also Published As

Publication number Publication date
MY6400075A (en) 1964-12-31
FR1333711A (en) 1963-08-02
BE584312A (en) 1960-05-04
GB870286A (en) 1961-06-14
US3356573A (en) 1967-12-05
DE1120446B (en) 1961-12-28
CH379493A (en) 1964-07-15

Similar Documents

Publication Publication Date Title
DE1072491B (en)
FR970M (en)
FR598M (en)
IT598490B (en)
FR464M (en)
AT221043B (en)
FR78798E (en)
AT217439B (en)
FR1194054A (en)
AT216803B (en)
AT216831B (en)
AT213472B (en)
AT219868B (en)
AT217982B (en)
LU36915A1 (en)
BE563272A (en)
BE438342A (en)
BE560415A (en)
BE558579A (en)
BE557464A (en)
BE555601A (en)
BE548156A (en)
BE543812A (en)
BE543487A (en)
BE539571A (en)